Remarkably, about 98% of APL patients show the translocation t (15; 17) (q24; q21) that generates an oncogenic fusion protein involving both RARA and a protein called PML, which is required for the assembly of PML-nuclear bodies surrounded by the chromatin of the nucleus. This evidence concerns the gene RARA and acute promyelocytic leukemia.